Navran Arash, Gouw Zeno A R, Klop Willem M, Schreuder Willem H, Donswijk Maarten L, Owers Emilia, de Boer Jan Paul, Smit Laura, Karssemakers Luc, van den Brekel Michiel, Al-Mamgani Abrahim
Department of Radiation Oncology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands.
Department of Head and Neck Oncology and Surgery, Netherlands Cancer Institute, Amsterdam, The Netherlands.
BMC Cancer. 2025 May 2;25(1):823. doi: 10.1186/s12885-025-14232-7.
Salvage neck dissection (ND) is the treatment of choice for residual neck disease after (chemo)radiotherapy for head-and-neck squamous cell carcinoma (HNSCC). Although ND is a relatively safe surgical procedure, several studies have shown that salvage ND will increase the morbidity of (chemo)radiotherapy with possible increase in acute and late toxicity and deterioration of quality-of-life. Therefore, unnecessary salvage ND need to be avoided. However, the available literature could not identify potential groups at higher risk of post-operative complications because of the missing demographic information and the heterogeneity in studies and outcome data. We aim to report on the types, rates, and severity of postoperative complications and to identify groups of patients at high risk of these complications.
Of 908 patients with node-positive HNSCC primarily treated with (chemo)radiotherapy between 2008 and 2022, 130 (14%) underwent salvage ND. Endpoints of the study are the incidence of G ≥ 2 and G3 postoperative complications, identification of risk factors for these complications and the oncologic outcomes.
Of all patients who underwent salvage ND, 41% still had vital tumor in ND-specimen (pN +). No G4-5 complications were reported. The incidence of G3 and G ≥ 2(CTCAE.v5) postoperative complications were 18% and 52%, respectively. Events reported as G3 complications were wound infection/dehiscence (n = 9), fistula (n = 4), bleeding (n = 4), tracheotomy (n = 6), dysphagia (n = 4), severe pneumonia and septicemia (n = 2), and frozen shoulder (n = 1). Seven patients had more than one type of G3 complications. Logistic regression showed that extent of salvage ND, size of the largest node and HPV-negative disease were independent predictors for G ≥ 2 complications. Multivariable analysis showed that G ≥ 2 complications was not associated with worse OS while HPV-negative and N3-disease were independent predictors for worse survival.
Of all patients who underwent salvage ND, 41% still had residual neck disease while 52% developed G ≥ 2 and 18% G3 complications. Although OS was not worse in these patients, accurate detection of residual neck disease is essential to spare considerable number of patients from unnecessary salvage ND with its possible complications. Patients with lymph nodes larger than 3 cm, HPV-negative disease and those treated by (modified)radical ND were at high risk of G ≥ 2 complications.
挽救性颈清扫术(ND)是头颈部鳞状细胞癌(HNSCC)放(化)疗后颈部残留病灶的首选治疗方法。尽管颈清扫术是一种相对安全的外科手术,但多项研究表明,挽救性颈清扫术会增加放(化)疗的发病率,可能会增加急性和晚期毒性,并使生活质量下降。因此,应避免不必要的挽救性颈清扫术。然而,由于缺乏人口统计学信息以及研究和结局数据的异质性,现有文献无法确定术后并发症风险较高的潜在人群。我们旨在报告术后并发症的类型、发生率和严重程度,并确定这些并发症的高危患者群体。
在2008年至2022年间,908例初治为放(化)疗的淋巴结阳性HNSCC患者中,130例(14%)接受了挽救性颈清扫术。该研究的终点是≥2级和3级术后并发症的发生率、这些并发症的危险因素识别以及肿瘤学结局。
在所有接受挽救性颈清扫术的患者中,41%的患者颈清扫标本中仍有存活肿瘤(pN+)。未报告4-5级并发症。3级和≥2级(CTCAE.v5)术后并发症的发生率分别为18%和52%。报告为3级并发症的事件包括伤口感染/裂开(n = 9)、瘘管(n = 4)、出血(n = 4)、气管切开术(n = 6)、吞咽困难(n = 4)、严重肺炎和败血症(n = 2)以及肩周炎(n = 1)。7例患者出现了不止一种3级并发症。逻辑回归显示,挽救性颈清扫术的范围、最大淋巴结大小和HPV阴性疾病是≥2级并发症的独立预测因素。多变量分析显示,≥2级并发症与较差的总生存期无关,而HPV阴性和N3期疾病是较差生存的独立预测因素。
在所有接受挽救性颈清扫术的患者中,41%仍有颈部残留病灶,52%发生了≥2级并发症,18%发生了3级并发症。尽管这些患者的总生存期没有更差,但准确检测颈部残留病灶对于避免大量患者接受不必要的挽救性颈清扫术及其可能的并发症至关重要。淋巴结大于3 cm、HPV阴性疾病以及接受(改良)根治性颈清扫术的患者发生≥2级并发症的风险较高。